IGLC7
Immunoglobulin lambda constant 7
Also known as: IGLC7_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- A0M8Q6
- Gene
- IGLC7
- Canonical length
- 106 aa
- Protein class
- Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for IGLC7 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
106 residues, UniProt reviewed canonical sequence.
>A0M8Q6|IGLC7
1 GQPKAAPSVT LFPPSSEELQ ANKATLVCLV SDFNPGAVTV AWKADGSPVK VGVETTKPSK
61 QSNNKYAASS YLSLTPEQWK SHRSYSCRVT HEGSTVEKTV APAECSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGLC7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 107 nTPM
Expression across tissuesHPA
Tissue
- stomach: 107 nTPM
- tonsil: 98 nTPM
- spleen: 95 nTPM
- duodenum: 84 nTPM
- salivary gland: 67 nTPM
- cerebral cortex: 55 nTPM
Single-cell type
- plasma cells: 773 nCPM
- foveolar cells: 226 nCPM
- mucous neck cells: 44 nCPM
- gastric chief cells: 24 nCPM
- b-cells: 19 nCPM
- neuroendocrine cells: 18 nCPM
Immune cell
- naive B-cell: 135 nTPM
- memory B-cell: 130 nTPM
- total PBMC: 26 nTPM
- plasmacytoid DC: 0.5 nTPM
- basophil: 0.3 nTPM
- naive CD8 T-cell: 0.2 nTPM
Brain region
- cerebellum: 3.4 nTPM
- cerebral cortex: 3.3 nTPM
- white matter: 3.3 nTPM
- hypothalamus: 2.5 nTPM
- pons: 2.3 nTPM
- midbrain: 2.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IGLC7.
Disease | ImmuneIEDB
Conditions an epitope on IGLC7 was assayed in.
- rheumatoid arthritis B cell
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGLC7 as an antibody target. Whether an autoantibody or antibody against IGLC7 could matter depends on whether native IGLC7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGLC7 is annotated at the cell surface, where native IGLC7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGLC7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...